JW Lifescience Corporation (KRX:234080)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,390
0.00 (0.00%)
At close: Jul 4, 2025, 3:30 PM KST
4.47%
Market Cap 197.58B
Revenue (ttm) 243.33B
Net Income (ttm) 44.96B
Shares Out 15.48M
EPS (ttm) 2,903.66
PE Ratio 4.39
Forward PE n/a
Dividend 500.00 (3.93%)
Ex-Dividend Date Dec 27, 2024
Volume 47,381
Average Volume 43,051
Open 12,390
Previous Close 12,390
Day's Range 12,380 - 12,620
52-Week Range 10,000 - 12,680
Beta 0.40
RSI 70.37
Earnings Date Aug 14, 2025

About JW Lifescience

JW Lifescience Corporation provides national infusion solutions in South Korea and internationally. The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin-si, South Korea. [Read more]

Sector Healthcare
Founded 1994
Employees 301
Stock Exchange Korea Stock Exchange
Ticker Symbol 234080
Full Company Profile

Financial Performance

In 2024, JW Lifescience's revenue was 222.48 billion, an increase of 7.55% compared to the previous year's 206.86 billion. Earnings were 43.99 billion, an increase of 56.29%.

Financial Statements

News

There is no news available yet.